Infection Control Surveillance Solutions Market Size By Component (Software {On-Premise, Web-Based}, Services), By End-user (Hospitals, Clinics, Specialty Centers, Ambulatory Surgical Centers), Industry Analysis Report, Growth Potential, Price Trends, Com

Infection Control Surveillance Solutions Market Size By Component (Software {On-Premise, Web-Based}, Services), By End-user (Hospitals, Clinics, Specialty Centers, Ambulatory Surgical Centers), Industry Analysis Report, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030.

The global infection control surveillance solutions market is poised to hold a sizeable valuation by 2030, driven by the increasing geriatric population and rising incidences of healthcare-acquired infections. According to the UN World population prospects, in 2019, around 703 million people across the globe were aged 65 years or over. These numbers are likely to increase by two folds to 1.5 billion in 2050.

Studies suggest that aging people show greater susceptibility to chronic disorders such as cardiovascular diseases, dementia, osteoporosis, etc. The diagnosis and treatment of these diseases require critical medical care and frequent hospital visits leading to the growing prevalence of HAIs and boosting the demand for infection control surveillance software.

Based on components, the infection control surveillance services market is expected to depict an appreciable growth rate over the forecast period. The increasing number of surgical interventions and the rapidly growing incidences of infectious and chronic health disorders among the geriatric population have emerged as leading factors contributing to the segmental expansion.

Compelled by the growing disease prevalence, governments, and associated authorities across several economies have been making huge investments to support the development of efficient infection surveillance services, thus streamlining the industry expansion.

For instance, in June 2022, the European Centre for Disease Prevention and Control (ECDC) announced the launch of EpiPulse- the European surveillance portal for infectious diseases. The service integrates several previously independent surveillance systems and offers new functionalities and seamless access to data in a single platform.

With respect to end-use, specialty centers are likely to gain appreciable momentum, with the estimated valuation expected to surpass USD 67 million by 2030. Specialty centers are healthcare establishments equipped to offer efficient, focused, and high-quality care. The primary factor backing the segment growth is the rapid expansion of the healthcare infrastructure globally due to the escalating public and private investments, driven by the emergence of contagious diseases like COVID-19 and monkeypox.

These public health emergencies require specialized medical care. The availability of emergency and acute care and a staff capable of treating patients with all health disorders will push the adoption of infection control surveillance solutions across specialty centers.

Regionally, Latin America (LATAM) infection control surveillance solution market is speculated to exhibit over 13% CAGR over the forecast period and may account for considerable revenue by 2030. The expansion of the regional industry can be attributed to the positive outlook of medical tourism and the presence of a massive population base.

Based on the latest UN estimations, as of August 23, 2021, the population of Latin America and The Caribbean stands at more than 660 million, accounting for over 8% of the total world population. The emergence of several health hazards associated with population growth, including poor vector control, sanitation, food, water contamination, etc., may lead to increased disease burden, strengthening the infection control surveillance market outlook.